Cshmedi Raises ￥10M in Pre-A Round of Financing

According to VCBeat, Cshmedi announced the completion of the Pre-A round of tens of millions, exclusively from Zhongsai Capital. Previously, Cshmedi competed its angel round invested by New Alliance Capital.

Founded by returning scientists and Shanghai Institute of Microsystems and Information Technology (SIMIT) of the Chinese Academy of Sciences in 2006, Cshmedi has cooperated with SIMIT to start the research and development of localized cardiac magnetic resonance (CMR) instrument. After more than ten years, the company has finally broken the technical barriers, successfully developed the magnetocardiography (MCG) technology with completely independent intellectual property rights, and reached the advanced level in equipment performance.

In 2017, after getting tens of millions in the angel round from New Alliance Capital, Cshmedi accelerated the clinical trial and registration process of its products, and in 2019 it became the first company in China to obtain the NMPA certification.

In China, the number of patients of myocardial ischemia caused by coronary heart diseases are about 11 million, accounting for 45% of non-hypertensive cardiovascular patients and 9% of all death causes. After years of technological evolution and a large number of clinical studies, MCG devices have been considered as a measurement with great potential in clinical diagnosis, especially for ischemic heart diseases because of the outstanding early diagnosis ability.

In addition to the approved MCG device, Cshmedi is also developing MCG devices for fetus and brain magnetic resonance at the same time to develop magnetic resonance imaging (MRI) devices and striving to become a world-renowned leading manufacturer in this field.

Zhongsai Capital focuses on equity investment and industrial investment, covering a variety of industries such as information technology, new consumption, big health, and real estate. Through the in-depth interpretation of China's macro and micro-economic trends and comprehensive analysis of the global market environment, the company is committed to achieving long-term asset appreciation.